2. Disease Areas
  3. Cancer Urogenital Disease
  4. Ovarian Cancer Urogenital Cancer
  5. Epithelial Ovarian Cancer

Epithelial Ovarian Cancer

Epithelial ovarian cancer is the most common type of ovarian malignancy, representing over 95% of cases, while non-epithelial ovarian cancers, including germ cell, sex-cord stromal, and small cell ovarian cancers, account for approximately 5%.

Epithelial Ovarian Cancer (5):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-P99229
    Upifitamab 2254118-43-7 99%
    Upifitamab is a humanized monoclonal antibody targeting NaPi2b. Upifitamab can be used to synthesize ADC such as Upfitamab rilsodotin. Upfitamab rilsodotin can be used in research for solid tumors including high-grade serious epithelial ovarian, fallopian tube and primary peritoneal cancer (OC). Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001).
    Upifitamab
  • HY-P990082
    Suvemcitug 1610010-57-5
    Suvemcitug (APX-003) is a selective humanized rabbit monoclonal IgG1 (κ) anti-VEGF antibody. Suvemcitug inhibits the binding of VEGF to purified VEGFR1 (IC50 = 21.0 ng/mL) and VEGFR2 (IC50 = 275.4 ng/mL). Suvemcitug suppresses tumor angiogenesis, tumor growth and metastasis. Suvemcitug is applicable to research related to epithelial ovarian cancer, fallopian tube cancer and primary peritoneal cancer.
    Suvemcitug
  • HY-P5407
    HD5 798569-33-2
    HD5 is an innate immune effector peptide and SARS-CoV Inhibitor. HD5 binds to the ligand-binding domain of angiotensin-converting enzyme-2 (ACE2) via multiple hydrogen bonds to competitively block the receptor, shielding it from viral recognition. HD5 can be used for the research of COVID-19, HPV16 infection, epithelial ovarian cancer, small-cell lung cancer, and colon cancer.
    HD5
  • HY-P5407A
    HD5 TFA
    HD5 TFA is an innate immune effector peptide and SARS-CoV Inhibitor. HD5 TFA binds to the ligand-binding domain of angiotensin-converting enzyme-2 (ACE2) via multiple hydrogen bonds to competitively block the receptor, shielding it from viral recognition. HD5 TFA can be used for the research of COVID-19, HPV16 infection, epithelial ovarian cancer, small-cell lung cancer, and colon cancer.
    HD5 TFA
  • HY-180127
    UR238 2728747-80-4
    UR238 is a proteasome inhibitor. UR238 reduces levels of the immunomodulator HE4. UR238 decreases PDL1 expression on cells. UR238 exhibits anticancer activity against epithelial ovarian cancer.
    UR238